Canada becomes first nation to give full approval to J&J vaccine

Canada has become the first country to give full approval to the Johnson & Johnson COVID-19 vaccine, Reuters reported.

The single-shot J&J vaccine will be available for citizens who are 18 years of age or older. Johnson & Johnson announced that Health Canada fully approved the vaccine on Wednesday.

The J&J vaccine was previously authorized under an interim order by the country, according to Reuters. 


“We are delighted by Health Canada’s decision to approve the Johnson & Johnson COVID-19 vaccine based on Phase 3 clinical data that proves the vaccine’s robust safety and efficacy,” J&J Global head of Research & Development Mathai Mammen said in a statement.

“As vaccination rates continue to climb, a vaccine that prevents severe disease and protects against COVID-related hospitalization and death will help ease the strain on healthcare systems and is an important option for people in Canada and around the world.”

Canada previously gave full approval to the two-shot Moderna and Pfizer COVID-19 vaccines in September. 


The country has reported 2,563 new daily COVID-19 infections but has administrated at least 60 million vaccines doses so far, Reuters reported. 

Canada’s government earlier this month also authorized the use of the Pfizer vaccine for children aged from 5 to 11 and booster doses for those who are 18 years and older. 

“Today marks the first major regulatory approval for the Johnson & Johnson COVID-19 vaccine and an important moment to recognize the dedication of everyone involved in our COVID-19 vaccine development, our partners, the regulators and clinical study participants. We are proud to have a COVID-19 vaccine available to protect people around the world and will continue to work to ensure global access,” J&J’s Vice Chairman of the Executive Committee and Chief Scientific Officer Paul Stoffels said in a statement.